How can I differentiate AECOPD from CAP+COPD patients?

John R Hurst (London, United Kingdom)

Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Session: Differentiating COPD exacerbations from pneumonia in COPD patients
Session type: Symposium
Number: 1956
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
John R Hurst (London, United Kingdom). How can I differentiate AECOPD from CAP+COPD patients?. International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015



Is there a difference in outcome according to etiology of COPD exacerbation in patients admitted to an ICU?
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011


Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?
Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021
Year: 2021



Acute exacerbations of COPD: are at-risk patients identified early and managed appropriately?
Source: Annual Congress 2008 - Management of COPD
Year: 2008



What are the needs of patients after discharge from hospital with an acute exacerbation of COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 127s
Year: 2007

How can we better treat infective exacerbations of COPD?
Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD
Year: 2012


Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Microorganisms isolated in COPD patients hospitalised for acute exacerbations and their clinical correlations
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


How do patients with COPD and chronic respiratory failure die and what can we do?
Source: Annual Congress 2012 - Advances in chronic respiratory failure in COPD: now out of its infancy
Year: 2012


Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation?
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


The rationality of the use of NIV in elderly patients with acute COPD exacerbation
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018

Prognosis and evolution of COPD patients hospitalized and treated with non invasive ventilation
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013


Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013


Do patients with an exacerbation of chronic obstructive pulmonary disease (COPD) really need to be admitted to a respiratory ward?
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013